The Journal for Nurse Practitioners
Volume 8, Issue 1 , Pages 56-60, January 2012

Hyperphosphatemia: Consequences and Management Strategies

  • Timothy V. Nguyen, PharmD

      Affiliations

    • Timothy V. Nguyen, PharmD, CCP, FASCP, is an assistant professor of pharmacy practice at Arnold & Marie Schwartz College of Pharmacy and Health Sciences at Long Island University (AMSCOP-LIU), an adjunct pharmacology professor at the graduate nursing program at Saint Peter's College, and a clinical pharmacy specialist in nephrology and dialysis at the Mount Sinai Medical Center.
    • ,
  • Amy Wang, PharmD

      Affiliations

    • Amy Wang, PharmD, MBA, BCPS, is an assistant professor of pharmacy practice at the AMSCOP-LIU in Brooklyn and clinical pharmacy specialist in cardiology at New York Methodist Hospital. In compliance with national ethical guidelines, the authors report no relationships with business or industry that would pose a conflict of interest.

Abstract 

Phosphorus si an essential element of the body and has many important functions. Hyperphosphatemia, or elevated levels of phosphorus, is defined based on patients' clinical status and often occurs in patients with acute or chronic kidney diseases. Prolonged periods of hyperphosphatemia are associated with such consequences as vascular calcification, organ failure, and mortality. Management includes correcting the underlying cause, hydrating patients to increase phosphorus excretion, and administering oral phosphate binders. Nurse practitioners and pharmacists should work together to identify and avoid exogenous sources of phosphorus, optimize patients' pharmacological therapy, and monitor patients' electrolytes.

Keywords:  acute kidney injury , chronic kidney disease , hyperphosphatemia , phosphate binder , phosphorus

 

PII: S1555-4155(11)00256-X

doi:10.1016/j.nurpra.2011.05.007

The Journal for Nurse Practitioners
Volume 8, Issue 1 , Pages 56-60, January 2012

Article Tools